SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $71.62 and last traded at $71.61, with a volume of 6412 shares. The stock had previously closed at $70.98.
SPDR S&P Pharmaceuticals ETF Stock Performance
The stock has a market capitalization of $533.23 million, a P/E ratio of 14.28 and a beta of 0.58. The firm has a 50-day moving average price of $67.19 and a 200 day moving average price of $60.30.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the business. Turtle Creek Wealth Advisors LLC purchased a new position in shares of SPDR S&P Pharmaceuticals ETF during the first quarter worth approximately $26,000. Royal Bank of Canada lifted its holdings in shares of SPDR S&P Pharmaceuticals ETF by 1.8% in the 4th quarter. Royal Bank of Canada now owns 27,098 shares of the company’s stock worth $1,518,000 after acquiring an additional 480 shares during the last quarter. Rockefeller Capital Management L.P. boosted its stake in shares of SPDR S&P Pharmaceuticals ETF by 3.2% in the 4th quarter. Rockefeller Capital Management L.P. now owns 20,043 shares of the company’s stock valued at $1,123,000 after purchasing an additional 627 shares in the last quarter. Western Wealth Management LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 1st quarter valued at $34,000. Finally, Advisory Services Network LLC bought a new position in shares of SPDR S&P Pharmaceuticals ETF during the 3rd quarter valued at $34,000.
About SPDR S&P Pharmaceuticals ETF
SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Stories
- Five stocks we like better than SPDR S&P Pharmaceuticals ETF
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
